胆嚢がんの世界市場

胆嚢がんの世界市場は2030年までに8,900万米ドルに達する見込み

2024年に7,500万米ドルと推定される胆嚢がんの世界市場は、分析期間2024-2030年にCAGR 2.9%で成長し、2030年には8,900万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである手術は、CAGR 2.2％を記録し、分析期間終了までに2,010万米ドルに達すると予測されます。化学療法セグメントの成長率は、分析期間中CAGR 2.1％と推定されます。

米国市場は2,040万米ドルと推定、中国はCAGR 5.3％で成長予測

米国の胆嚢がん市場は2024年に2,040万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1,720万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.2%と2.2%と予測されています。欧州では、ドイツがCAGR 1.6%で成長すると予測されています。

世界の胆嚢がん市場- 主要動向と促進要因のまとめ

なぜ胆嚢がんは世界のがん領域で関心が高まっているのか？

胆嚢がんは、他の消化器系悪性腫瘍と比較すると比較的まれではあるもの、診断がしばしば遅れ、進行が激しく、予後不良であるため、世界の腫瘍学で関心が高まっています。このがんは胆嚢の上皮内膜に発生し、初期には無症状であることが多いため、根治的治療の選択肢が限られている場合には発見が遅れます。胆石症や慢性胆嚢炎のような良性の胆嚢疾患に擬態して発症することが多いため、多くの地域、特に診断インフラが限られている低・中所得国では、誤診や過少報告の原因となっています。世界的に見ると、南米（特にチリ）、東南アジア、インド北部などの地域では、遺伝的素因、食事要因、慢性胆嚢感染症、胆石の有病率などの複合的な要因により、罹患率が有意に高いと報告されています。また、性別も関与しており、ホルモンの影響や女性の胆石症罹患率の高さから、男性よりも女性の罹患率が高いです。さらに、環境因子、肥満、ある種の発がん物質への暴露、胆嚢ポリープの既往などがリスクの一因として浮上しています。平均寿命が延び、画像診断へのアクセスが向上するにつれ、世界中でより多くの症例が確認されるようになり、胆嚢がんは公衆衛生システムやがん研究者の注目を集めています。死亡率が高く、効果的なスクリーニング方法が確立されていないことから、胆嚢がんは、臨床と研究の両領域において早急な対応が必要な、腫瘍学のフロンティアとなる課題です。

胆嚢がんに対する現在の診断・治療アプローチはどのように進化しているか？

胆嚢がんの診断と治療の状況は、この疾患のとらえどころのなさと限られた治療反応性のため、大きな課題を抱えながらも徐々に進化しています。超音波検査、CTスキャン、MRIなどの画像診断が一般的に初期評価に用いられるが、早期診断に必要な特異性に欠けることが多いです。超音波内視鏡（EUS）やPET検査は、病期診断の精度を高め、転移を検出するために、専門施設で採用されるようになってきています。生検による組織学的確認は依然として不可欠であるが、解剖学的位置関係や播種の危険性から、術後にしか実行できないことが多いです。治療に関しては、手術が唯一の根治的選択肢であることに変わりはなく、切除可能な症例では拡大胆嚢摘出術と肝切除が標準的です。しかし、患者の大部分は進行した病変を呈しており、生存率に対する効果はわずかであるにもかかわらず、ゲムシタビンとシスプラチンを中心とする全身化学療法が依然として主流です。放射線療法と緩和ケアは、転移症例の症状管理と生活の質の改善に役割を果たしています。近年、HER2阻害剤、PD-1/PD-L1阻害剤のようなチェックポイント阻害剤、VEGFを標的とした治療を検討する臨床試験が行われるなど、標的治療や免疫療法への関心が高まっています。リキッドバイオプシーと分子プロファイリングもまた、個別化治療レジメンの指針として支持を集めています。このような進歩にもかかわらず、胆嚢がんは依然として治療が困難であり、特にステージIIIおよびIVの患者における5年生存率は依然として悲惨なほど低いです。診断・治療技術の進化は希望をもたらし続けているが、早期発見ツールや革新的な治療法への幅広いアクセスが有意義な進歩には不可欠です。

精密医療とゲノム研究は治療にどのような役割を果たすのか？

精密医療とゲノム研究は、治療選択肢が限られ、予後不良という歴史的な特徴を持つ胆嚢がんの治療において、新たな可能性を解き放ち始めています。次世代シークエンシング（NGS）技術や分子診断ツールの利用可能性が高まるにつれ、研究者は標的治療に利用できる可能性のある実用的な変異や経路を特定しつつあります。例えば、KRAS、TP53、ERBB2（HER2）、PIK3CA遺伝子の変異は、胆嚢がん症例のかなりの部分において証明されており、高精度薬剤開発の潜在的な標的となっています。特にHER2過剰発現は、トラスツズマブや他のHER2指向性薬剤を用いた有望な初期段階の臨床試験データにより、治療の道として模索されています。同様に、免疫チェックポイント阻害剤を含む臨床試験では、他の消化器がんでみられるように、腫瘍の変異負荷やマイクロサテライト不安定性の高い胆嚢がん患者が免疫療法から利益を得られるかどうかが検討されています。早期発見、治療効果のモニタリング、微小残存病変の検出のための非侵襲的方法として、リキッドバイオプシー技術も勢いを増しています。さらに、人工知能とバイオインフォマティクスの統合により、大規模なゲノムデータセットから新規バイオマーカーや治療可能な標的を同定することが可能になりつつあります。より多くの胆嚢がんに特化したデータベースやバイオバンクが確立されるにつれて、分子プロファイルに基づいて患者を層別化し、治療を個別化する機会がますます現実味を帯びてきています。これらの進歩はまだ初期段階であるが、胆嚢がんの管理におけるパラダイムシフトを象徴しています。

胆嚢がんケアの未来を形作る市場力学と世界ヘルス力学とは？

胆嚢がん診断薬と治療薬の世界市場は、医療投資の増加、希少がんに対する認識の高まり、早期発見と個別化医療の重視の高まりなど、いくつかの交錯する力によって影響を受けています。南アジアやラテンアメリカのような罹患率の高い地域では、公衆衛生キャンペーンや診断インフラの改善が早期発見や症例報告の増加につながっており、それが効果的な治療選択肢や研究資金に対する需要を後押ししています。製薬会社やバイオテクノロジー企業は、希少疾病用医薬品政策のもとで提供されるインセンティブや、ニッチで標的を絞った治療法の有効性が高まっていることから、胆嚢がんを含む希少疾病用がんの適応症に高い関心を示しています。いくつかの新興諸国では、国民皆保険制度への移行により、画像診断、外科手術、化学療法へのアクセスも改善されつつあるが、医療における格差は依然として大きな問題です。さらに、胆道がんに焦点を当てた国際的な共同研究やコンソーシアムは、知識の共有、臨床試験の募集、バイオマーカーの発見を促進しています。COVID-19の大流行は、当初はがん医療サービスを減速させたが、デジタルヘルスの導入や遠隔腫瘍学モデルも加速させており、胆嚢がん患者の長期モニタリングやセカンドオピニオンへのアクセスを改善する可能性があります。医療技術評価（HTA）と価値に基づくケアモデルは、特に新規の標的治療薬の薬価と償還の決定に影響を与え始めています。プレシジョンオンコロジーが拡大し、希少がんが研究機関や規制当局から注目されるようになるにつれ、胆嚢がんケアの将来は、患者中心、データ情報、世界の連携がより強化される方向にあります。

セグメント

治療タイプ（手術、化学療法、放射線療法、免疫療法、標的療法、その他の治療タイプ）、がんタイプ（腺がん、扁平上皮がん、腺扁平上皮がん、小細胞がん、その他のがんタイプ）、流通チャネル（病院薬局、小売薬局、オンライン薬局、その他の流通チャネル）

調査対象企業の例（注目の44社）

• AstraZeneca
• Bayer AG
• Beigene
• Boston Scientific Corporation
• Bristol-Myers Squibb Company
• Cipla Limited
• Compass Therapeutics
• Crown Bioscience
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GLS Pharma Ltd.
• Incyte Corporation
• Intuitive Surgical
• Jazz Pharmaceuticals
• Johnson & Johnson
• Medtronic plc
• Olympus Corporation
• OncoTherapy Science, Inc.
• Pfizer Inc.
• Sanofi

AI統合

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Gallbladder Cancer Market to Reach US$89.0 Million by 2030

The global market for Gallbladder Cancer estimated at US$75.0 Million in the year 2024, is expected to reach US$89.0 Million by 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Surgery, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$20.1 Million by the end of the analysis period. Growth in the Chemotherapy segment is estimated at 2.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.4 Million While China is Forecast to Grow at 5.3% CAGR

The Gallbladder Cancer market in the U.S. is estimated at US$20.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$17.2 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Gallbladder Cancer Market - Key Trends & Drivers Summarized

Why Is Gallbladder Cancer a Growing Concern in Global Oncology?

Gallbladder cancer, though relatively rare compared to other gastrointestinal malignancies, is becoming an increasing concern in global oncology due to its often late diagnosis, aggressive progression, and poor prognosis. This cancer originates in the epithelial lining of the gallbladder and is frequently asymptomatic in its early stages, leading to delayed detection when curative treatment options are limited. Its subtle onset-often mimicking benign gallbladder conditions like cholelithiasis or chronic cholecystitis-results in misdiagnosis or underreporting in many regions, especially in low- and middle-income countries with limited diagnostic infrastructure. Globally, regions such as South America (particularly Chile), Southeast Asia, and Northern India report significantly higher incidence rates, largely due to a combination of genetic predisposition, dietary factors, chronic gallbladder infections, and the prevalence of gallstones. Gender also plays a role, with females being more commonly affected than males, potentially due to hormonal influences and higher rates of gallstone disease in women. Furthermore, environmental factors, obesity, exposure to certain carcinogens, and a history of gallbladder polyps are emerging as contributing risks. As life expectancy increases and access to diagnostic imaging improves, more cases are being identified worldwide, putting gallbladder cancer on the radar of public health systems and cancer researchers. With its high mortality rate and the lack of effective screening methods, gallbladder cancer represents a challenging frontier in oncology that requires urgent attention in both clinical and research domains.

How Are Current Diagnostic and Therapeutic Approaches Evolving for Gallbladder Cancer?

The diagnosis and treatment landscape for gallbladder cancer is gradually evolving, albeit with significant challenges due to the disease’s elusive nature and limited therapeutic responsiveness. Imaging modalities such as ultrasound, CT scans, and MRI are typically used for initial assessment, but these often lack the specificity required for early-stage diagnosis. Endoscopic ultrasound (EUS) and PET scans are increasingly being employed in specialized centers to improve staging accuracy and detect metastases. Histological confirmation via biopsy remains essential, though often only feasible post-surgically due to the anatomical positioning and risk of seeding. In terms of treatment, surgery remains the only curative option, with extended cholecystectomy and liver resection being standard for resectable cases. However, the majority of patients present with advanced disease, for which systemic chemotherapy-primarily gemcitabine and cisplatin-remains the mainstay, despite modest survival benefits. Radiation therapy and palliative care play roles in symptom management and life-quality improvement for metastatic cases. Recent years have seen a surge in interest in targeted therapies and immunotherapy, with clinical trials exploring HER2 inhibitors, checkpoint inhibitors like PD-1/PD-L1 blockers, and VEGF-targeted treatments. Liquid biopsies and molecular profiling are also gaining traction for guiding personalized treatment regimens. Despite these advances, gallbladder cancer remains difficult to treat, with five-year survival rates still dismally low, especially in Stage III and IV patients. The evolution of diagnostic and treatment technologies continues to bring hope, but broader access to early detection tools and innovative therapies is essential for meaningful progress.

What Role Is Precision Medicine and Genomic Research Playing in Gallbladder Cancer Treatment?

Precision medicine and genomic research are beginning to unlock new possibilities in the treatment of gallbladder cancer, a disease historically characterized by limited treatment options and poor outcomes. With the growing availability of next-generation sequencing (NGS) technologies and molecular diagnostic tools, researchers are identifying actionable mutations and pathways that may be exploited for targeted therapy. For instance, alterations in the KRAS, TP53, ERBB2 (HER2), and PIK3CA genes have been documented in a significant subset of gallbladder cancer cases, offering potential targets for precision drug development. HER2 overexpression, in particular, is being explored as a therapeutic avenue with encouraging early-phase clinical trial data using trastuzumab and other HER2-directed agents. Similarly, trials involving immune checkpoint inhibitors are investigating whether gallbladder cancer patients with high tumor mutational burden or microsatellite instability might benefit from immunotherapy, as has been seen in other gastrointestinal cancers. Liquid biopsy techniques are also gaining momentum as non-invasive methods for early detection, monitoring treatment response, and detecting minimal residual disease. Moreover, integration of artificial intelligence and bioinformatics is enabling the identification of novel biomarkers and druggable targets from large genomic datasets. As more gallbladder cancer-specific databases and biobanks are established, the opportunity to stratify patients and personalize therapy based on molecular profiles is becoming increasingly viable. While these advancements are still in early stages, they represent a paradigm shift in the management of gallbladder cancer-from a one-size-fits-all model to a more tailored, data-driven approach that could significantly improve outcomes in the long term.

What Market Forces and Global Health Dynamics Are Shaping the Future of Gallbladder Cancer Care?

The global market for gallbladder cancer diagnostics and therapeutics is being influenced by several intersecting forces, including rising healthcare investments, increasing awareness of rare cancers, and the growing emphasis on early detection and personalized medicine. In high-incidence regions like South Asia and Latin America, public health campaigns and improvements in diagnostic infrastructure are leading to earlier recognition and increased case reporting, which in turn drives demand for effective treatment options and research funding. Pharmaceutical and biotech companies are showing greater interest in orphan oncology indications, including gallbladder cancer, due to the incentives provided under orphan drug policies and the increasing viability of niche, targeted therapies. The shift toward universal healthcare in several developing countries is also improving access to imaging, surgical services, and chemotherapy, though disparities in care remain a significant issue. Moreover, international collaborations and consortia focused on biliary tract cancers are facilitating knowledge sharing, clinical trial recruitment, and biomarker discovery. The COVID-19 pandemic, while initially slowing down cancer care services, has also accelerated digital health adoption and tele-oncology models, which may improve long-term monitoring and access to second opinions for gallbladder cancer patients. Health technology assessments (HTAs) and value-based care models are beginning to influence drug pricing and reimbursement decisions, particularly for novel targeted therapies. As precision oncology expands and rare cancers gain more attention from research institutions and regulators, the future of gallbladder cancer care is poised to become more patient-centric, data-informed, and globally coordinated-though continued investment and advocacy will be critical to translate scientific advances into improved survival and quality of life for patients.

SCOPE OF STUDY:

The report analyzes the Gallbladder Cancer market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Other Treatment Types); Cancer Type (Adenocarcinoma, Squamous Cell Carcinoma, Adenosquamous Carcinoma, Small Cell Carcinoma, Other Cancer Types); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• AstraZeneca
• Bayer AG
• Beigene
• Boston Scientific Corporation
• Bristol-Myers Squibb Company
• Cipla Limited
• Compass Therapeutics
• Crown Bioscience
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GLS Pharma Ltd.
• Incyte Corporation
• Intuitive Surgical
• Jazz Pharmaceuticals
• Johnson & Johnson
• Medtronic plc
• Olympus Corporation
• OncoTherapy Science, Inc.
• Pfizer Inc.
• Sanofi

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Gallbladder Cancer - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Low Survival Rates and Late Diagnosis Challenges Throw the Spotlight on Gallbladder Cancer Research
  • Rising Incidence in Specific Geographies Propels Clinical Interest in Region-Specific Risk Factors
  • Push Toward Precision Oncology Expands Market for Biomarker-Based Gallbladder Cancer Therapies
  • Growth in Genomic Profiling and Liquid Biopsy Technologies Strengthens Early Detection Capabilities
  • Increased Funding for Rare Cancers Drives Clinical Trial Activity in Gallbladder Oncology
  • Rising Awareness Campaigns in High-Risk Regions Spur Screening and Early Referral Rates
  • Integration of Immunotherapy in Solid Tumor Protocols Fuels Research in Gallbladder Cancer Targets
  • Push for Companion Diagnostics Creates Opportunities for Pharma-Diagnostic Co-Development Models
  • Advancements in AI-Based Imaging Analytics Support Radiological Identification of Gallbladder Abnormalities
  • Personalized Treatment Approaches Drive Demand for Molecular Subtyping and Prognostic Tools
  • Global Expansion of Oncology Centers Enhances Access to Standardized Care in Underserved Areas
  • Multi-Cancer Panels and NGS Panels Begin Including Gallbladder-Associated Markers for Risk Stratification
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Gallbladder Cancer Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Gallbladder Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Gallbladder Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Gallbladder Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Small Cell Carcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Small Cell Carcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Small Cell Carcinoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Adenocarcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Adenocarcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Adenocarcinoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Squamous Cell Carcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Squamous Cell Carcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Squamous Cell Carcinoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Adenosquamous Carcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Adenosquamous Carcinoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Adenosquamous Carcinoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Online Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: USA 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: Canada 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• JAPAN
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• CHINA
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• EUROPE
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Gallbladder Cancer by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Gallbladder Cancer by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Gallbladder Cancer by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• FRANCE
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• GERMANY
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 125: UK Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 131: UK Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: UK Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 133: UK 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 140: Spain Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Spain Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 142: Spain 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 149: Russia Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Russia Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 151: Russia 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Rest of Europe Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 160: Rest of Europe 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Gallbladder Cancer by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Gallbladder Cancer by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Gallbladder Cancer by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Asia-Pacific Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 172: Asia-Pacific 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 179: Australia Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Australia Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 181: Australia 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• INDIA
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 182: India Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 188: India Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: India Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 190: India 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 197: South Korea Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: South Korea Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 199: South Korea 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Asia-Pacific Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Gallbladder Cancer by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Gallbladder Cancer by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Gallbladder Cancer by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 218: Latin America Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Latin America Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 220: Latin America 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 227: Argentina Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Argentina Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 229: Argentina 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 236: Brazil Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Brazil Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 238: Brazil 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 245: Mexico Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Mexico Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 247: Mexico 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Latin America Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 256: Rest of Latin America 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Gallbladder Cancer by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Gallbladder Cancer by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Gallbladder Cancer by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 266: Middle East Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Middle East Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 268: Middle East 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 275: Iran Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Iran Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 277: Iran 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 284: Israel Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Israel Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 286: Israel 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Saudi Arabia Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 295: Saudi Arabia 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 302: UAE Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: UAE Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 304: UAE 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Middle East Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Middle East 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030
• AFRICA
  • Gallbladder Cancer Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Gallbladder Cancer by Treatment Type - Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Gallbladder Cancer by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Gallbladder Cancer by Cancer Type - Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Gallbladder Cancer by Cancer Type - Percentage Breakdown of Value Sales for Small Cell Carcinoma, Other Cancer Types, Adenocarcinoma, Squamous Cell Carcinoma and Adenosquamous Carcinoma for the Years 2015, 2025 & 2030
  • TABLE 320: Africa Recent Past, Current & Future Analysis for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Africa Historic Review for Gallbladder Cancer by Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 322: Africa 15-Year Perspective for Gallbladder Cancer by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Distribution Channels for the Years 2015, 2025 & 2030

IV. COMPETITION